(Q33333991)

English

Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Anna Dmoszyńska

5

object named as

Dmoszyńska A

1 reference

Europe PubMed Central

25 July 2017

Ewa Lech-Marańda

3

object named as

Lech-Marańda E

1 reference

Europe PubMed Central

25 July 2017

1

object named as

Robak T

1 reference

Europe PubMed Central

25 July 2017

author name string

Wrzesień-Kuś A

2

1 reference

Europe PubMed Central

25 July 2017

Kowal M

4

1 reference

Europe PubMed Central

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2000

1 reference

Europe PubMed Central

25 July 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

25 July 2017

39

1 reference

Europe PubMed Central

25 July 2017

1-2

1 reference

Europe PubMed Central

25 July 2017

121-129

1 reference

Europe PubMed Central

25 July 2017

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190009053545

21 January 2018

2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190009053545

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.3109%2F10428190009053545

21 January 2018

IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428190009053545

21 January 2018

Identifiers

10.3109/10428190009053545

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33333991&oldid=2118185177"